Voyager Therapeutics Stock Had Been Beaten Down. Here’s Why It’s Soaring.

Shares of a tiny biotech called Voyager Therapeutics jumped 46% connected Wednesday aft the institution said Pfizer had licensed entree to its cistron therapy exertion successful a woody worthy up to $630 million.

According to Voyager (ticker: VYGR), Pfizer volition wage $30 cardinal up beforehand for options to usage proteins known arsenic capsids developed by Voyager successful its cistron therapy programs. The capsids are shells that overgarment the viruses utilized to present familial worldly arsenic portion of cistron therapy. Voyager’s exertion identifies capsids designed to much effectively...